Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1213-1223
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1213
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1213
Figure 3 Vonoprazan triple therapy and tegoprazan triple therapy vs conventional proton pump inhibitor triple therapy - observational studies.
A: Vonoprazan triple therapy; B: Tegoprazan triple therapy. RR: Risk ratio; CI: Confidence interval.
- Citation: Kanu JE, Soldera J. Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(9): 1213-1223
- URL: https://www.wjgnet.com/1007-9327/full/v30/i9/1213.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i9.1213